ATE140233T1 - Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide - Google Patents
Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptideInfo
- Publication number
- ATE140233T1 ATE140233T1 AT89905259T AT89905259T ATE140233T1 AT E140233 T1 ATE140233 T1 AT E140233T1 AT 89905259 T AT89905259 T AT 89905259T AT 89905259 T AT89905259 T AT 89905259T AT E140233 T1 ATE140233 T1 AT E140233T1
- Authority
- AT
- Austria
- Prior art keywords
- antigens
- antibodies
- cellular receptors
- immunogenic
- specificity
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 6
- 102000036639 antigens Human genes 0.000 title abstract 6
- 108091007433 antigens Proteins 0.000 title abstract 6
- 230000001413 cellular effect Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title 1
- 102000005962 receptors Human genes 0.000 abstract 3
- 108020003175 receptors Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19402688A | 1988-05-13 | 1988-05-13 | |
| US32632889A | 1989-03-21 | 1989-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE140233T1 true ATE140233T1 (de) | 1996-07-15 |
Family
ID=26889616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89905259T ATE140233T1 (de) | 1988-05-13 | 1989-04-28 | Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0370090B1 (de) |
| JP (1) | JPH02504284A (de) |
| AT (1) | ATE140233T1 (de) |
| DE (1) | DE68926813T2 (de) |
| WO (1) | WO1989010939A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5637677A (en) | 1987-07-16 | 1997-06-10 | The Trustees Of The University Of Pennsylvania | Biologically active compounds and methods of constructing and using the same |
| US5969109A (en) * | 1990-02-28 | 1999-10-19 | Bona; Constantin | Chimeric antibodies comprising antigen binding sites and B and T cell epitopes |
| CA2091258A1 (en) * | 1990-09-14 | 1992-03-15 | William Williams | Design of bioactive peptides based on immunoglobulin structure |
| US5641867A (en) * | 1993-09-29 | 1997-06-24 | The Trustees Of Columbia University In The City Of New York | Antibody which specifically binds to endothelial-monocyte activating polypeptide II |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683295A (en) * | 1984-05-24 | 1987-07-28 | Scripps Clinic And Research Foundation | Method for the preparation of anti-receptor antibodies |
| US4761371A (en) * | 1985-02-12 | 1988-08-02 | Genentech, Inc. | Insulin receptor |
| IL80678A (en) * | 1985-11-19 | 1999-05-09 | Schering Biotech Corp | Human interleukin-4 |
| EP0241139A3 (de) * | 1986-03-13 | 1989-04-19 | Merck & Co. Inc. | Antiidiotypischer Coccidiaimpfstoff |
| WO1988007375A1 (en) * | 1987-03-23 | 1988-10-06 | Hiver Limited | Novel vaccines |
| EP0366718B1 (de) * | 1987-05-29 | 1995-05-10 | Tanox Biosystems, Inc. | Hiv-1 neutralisierende monoklonale antikörper |
-
1989
- 1989-04-28 WO PCT/US1989/001815 patent/WO1989010939A1/en active IP Right Grant
- 1989-04-28 DE DE68926813T patent/DE68926813T2/de not_active Expired - Fee Related
- 1989-04-28 EP EP89905259A patent/EP0370090B1/de not_active Expired - Lifetime
- 1989-04-28 JP JP1505073A patent/JPH02504284A/ja active Pending
- 1989-04-28 AT AT89905259T patent/ATE140233T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE68926813T2 (de) | 1997-07-17 |
| WO1989010939A1 (en) | 1989-11-16 |
| EP0370090A1 (de) | 1990-05-30 |
| DE68926813D1 (de) | 1996-08-14 |
| JPH02504284A (ja) | 1990-12-06 |
| EP0370090B1 (de) | 1996-07-10 |
| EP0370090A4 (en) | 1990-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO934801L (no) | CTL4A reseptor, fusjonsproteiner som inneholder den og anvendelse derav | |
| DE3750339D1 (de) | HTLV-III umhüllende Peptiden. | |
| DK0677533T3 (da) | Antistoffer mod epitoper med homologi til selv-antigener, fremgangsmåder til fremstilling og anvendelser deraf | |
| KR880006357A (ko) | 인터류킨-i에 대한 항체 | |
| WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
| ATE115412T1 (de) | Anti-idiotyp-antikörper gegen antimenschliche hochmolekulare, an melanomen assoziierte antigene. | |
| WO1999013907A3 (en) | Methods to improve immunogenicity of antigens and specificity of antibodies | |
| ATE140233T1 (de) | Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide | |
| KR890003958A (ko) | 단일클로온 항체들에 의해 확인되는 리스테리아속-특이 항원 | |
| ATE72400T1 (de) | Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen. | |
| DK0428485T3 (da) | Nye anti-idiotypiske monoklone antistoffer | |
| DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
| KR910005887A (ko) | 면역원성 물질의 고-보존된 아미노산 서열에 대한 항체, 이의 항체의 제조 방법 및 면역 감정에서의 이의 용도 | |
| DK340887A (da) | Antigenisk peptid isoleret fra 28 kd proteinet fras. mansoni og fremgangsmaade til dets isolering, monoklonale antistoffer, der genkender mindst en epitop af peptidet og dets anvendelse til syntese af antistoffer | |
| LIN et al. | Induction of antibodies to the bluetongue virus core polypeptide VP7 in sheep by internal image rabbit antiidiotypic antibodies | |
| JPS6471480A (en) | Cell line producing monoclonal antibody and monoclonal antibody produced therefrom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |